Tissue- and cell-specific mitochondrial defect in Parkin-deficient mice

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Damiano, Maria ^a,b,c   Gautier, Clément A ^a,b,c   Bulteau, Anne Laure ^c,d,e   Ferrando Miguel, Rosa ^a,b,c   Gouarne, Caroline ^f   Paoli, Marc Giraudon ^f   Pruss, Rebecca ^f   Auchère, Françoise ^g   L'Hermitte Stead, Caroline ^c,d,e   Bouillaud, Frédéric ^c,d,e   Brice, Alexis ^a,b,c   Corti, Olga ^a,b,c   Lombès, Anne ^c,d,e  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c CNRS   (France)

^d INSTITUT COCHIN   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f Case 915 Parc Scientifique de Luminy   (France)

^g INSTITUT JACQUES MONOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; PARKIN; PROTEASOME; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUPEROXIDE DISMUTASE; UBIQUITIN PROTEIN LIGASE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL SPECIFICITY; CORPUS STRIATUM; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE; GENE EXPRESSION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PARK2 GENE; SOD2 GENE; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; CELL RESPIRATION; DEFICIENCY; EMBRYOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL RESPIRATION; CORPUS STRIATUM; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MITOCHONDRIA; ORGAN SPECIFICITY; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; UBIQUITIN-PROTEIN LIGASES;

EID: 84903533942     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0099898     Document Type: Article

References (64)

1. Schapira AH, Cooper JM, Dexter D, Jenner P, Clark JB, et al. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1: 1269. (Pubitemid 19140359)
2. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AHV, et al. (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115: ?
3. Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism. Neurobiol Dis 51: 35-42.
4. Cardoso SM (2011) The mitochondrial cascade hypothesis for Parkinson's disease. Curr Pharm Des 17: 3390-3397.
5. Corti O, Lesage S, Brice A (2011) What genetics tells us about the causes and mechanisms of Parkinson's disease. Physiol Rev 91: 1161-1218.
6. Darios F, Corti O, Lucking CB, Hampe C, Muriel MP, et al. (2003) Parkin prevents mitochondrial swelling and cytochrome c release in mitochondria- dependent cell death. Hum Mol Genet 12: 517-526. (Pubitemid 36305590)
7. Canet-Aviles RM, Wilson MA, Miller DW, Ahmad R, McLendon C, et al. (2004) The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc Natl Acad Sci U S A 101: 9103-9108. (Pubitemid 38781618)
8. Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, et al. (2004) Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304: 1158-1160. (Pubitemid 38661852)
9. Corti O, Brice A (2013) Mitochondrial quality control turns out to be the principal suspect in parkin and PINK1-related autosomal recessive Parkinson's disease. Curr Opin Neurobiol 23: 100-108.
10. Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803.
11. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, et al. (2010) PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298.
12. Narendra D, Walker JE, Youle R (2012) Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. Cold Spring Harb Perspect Biol 4.
13. Vives-Bauza C, Zhou C, Huang Y, Cui M, de Vries RL, et al. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 107: 378-383.
14. Geisler S, Holmstrom KM, Treis A, Skujat D, Weber SS, et al. (2010) The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations. Autophagy 6: 871-878.
15. Matsuda N, Sato S, Shiba K, Okatsu K, Saisho K, et al. (2010) PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy. J Cell Biol 189: 211-221.
16. Yang Y, Gehrke S, Imai Y, Huang Z, Ouyang Y, et al. (2006) Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc Natl Acad Sci U S A 103: 10793-10798. (Pubitemid 44078055)
17. Poole AC, Thomas RE, Andrews LA, McBride HM, Whitworth AJ, et al. (2008) The PINK1/Parkin pathway regulates mitochondrial morphology. Proc Natl Acad Sci U S A 105: 1638-1643. (Pubitemid 351346567)
18. Deng H, Dodson MW, Huang H, Guo M (2008) The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A 105: 14503-14508.
19. Wang X, Winter D, Ashrafi G, Schlehe J, Wong YL, et al. (2011) PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147: 893-906.
20. Liu S, Sawada T, Lee S, Yu W, Silverio G, et al. (2012) Parkinson's disease-associated kinase PINK1 regulates Miro protein level and axonal transport of mitochondria. PLoS Genet 8: e1002537.
21. Shin JH, Ko HS, Kang H, Lee Y, Lee YI, et al. (2011) PARIS (ZNF746) repression of PGC-1alpha contributes to neurodegeneration in Parkinson's disease. Cell 144: 689-702.
22. Pacelli C, De Rasmo D, Signorile A, Grattagliano I, di Tullio G, et al. (2011) Mitochondrial defect and PGC-1alpha dysfunction in parkin-associated familial Parkinson's disease. Biochim Biophys Acta 1812: 1041-1053.
23. Exner N, Treske B, Paquet D, Holmstrom K, Schiesling C, et al. (2007) Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin. J Neurosci 27: 12413-12418. (Pubitemid 350085485)
24. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, et al. (2009) PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death. Mol Cell 33: 627-638.
25. Mortiboys H, Thomas KJ, Koopman WJ, Klaffke S, Abou-Sleiman P, et al. (2008) Mitochondrial function and morphology are impaired in parkin-mutant fibroblasts. Ann Neurol 64: 555-565.
26. Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, et al. (2009) Parkinson's disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1: 99-111.
27. Zhang C, Lin M, Wu R, Wang X, Yang B, et al. (2011) Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proc Natl Acad Sci U S A 108: 16259-16264.
28. Grunewald A, Gegg ME, Taanman JW, King RH, Kock N, et al. (2009) Differential effects of PINK1 nonsense and missense mutations on mitochondrial function and morphology. Exp Neurol 219: 266-273.
29. Grunewald A, Voges L, Rakovic A, Kasten M, Vandebona H, et al. (2010) Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts. PLoS One 5: e12962.
30. Muftuoglu M, Elibol B, Dalmizrak O, Ercan A, Kulaksiz G, et al. (2004) Mitochondrial complex I and IV activities in leukocytes from patients with parkin mutations. Mov Disord 19: 544-548.
31. Sterky FH, Lee S, Wibom R, Olson L, Larsson NG (2011) Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc Natl Acad Sci U S A 108: 12937-12942.
32. Van Laar VS, Arnold B, Cassady SJ, Chu CT, Burton EA, et al. (2011) Bioenergetics of neurons inhibit the translocation response of Parkin following rapid mitochondrial depolarization. Hum Mol Genet 20: 927-940.
33. Gautier CA, Kitada T, Shen J (2008) Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress. Proc Natl Acad Sci U S A 105: 11364-11369.
34. Gispert S, Ricciardi F, Kurz A, Azizov M, Hoepken HH, et al. (2009) Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration. PLoS One 4: e5777.
35. Palacino JJ, Sagi D, Goldberg MS, Krauss S, Motz C, et al. (2004) Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J Biol Chem 279: 18614-18622. (Pubitemid 38623283)
36. Periquet M, Corti O, Jacquier S, Brice A (2005) Proteomic analysis of parkin knockout mice: alterations in energy metabolism, protein handling and synaptic function. J Neurochem 95: 1259-1276. (Pubitemid 41779252)
37. Stichel CC, Zhu XR, Bader V, Linnartz B, Schmidt S, et al. (2007) Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage. Hum Mol Genet 16: 2377-2393. (Pubitemid 47514484)
38. Goldberg MS, Fleming SM, Palacino JJ, Cepeda C, Lam HA, et al. (2003) Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons. J Biol Chem 278: 43628-43635. (Pubitemid 37345989)
39. Itier JM, Ibanez P, Mena MA, Abbas N, Cohen-Salmon C, et al. (2003) Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse. Hum Mol Genet 12: 2277-2291. (Pubitemid 37160872)
40. Von Coelln R, Thomas B, Savitt JM, Lim KL, Sasaki M, et al. (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci U S A 101: 10744-10749. (Pubitemid 38955813)
41. Perez FA, Palmiter RD (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc Natl Acad Sci U S A 102: 2174-2179. (Pubitemid 40262031)
42. Fournier M, Vitte J, Garrigue J, Langui D, Dullin JP, et al. (2009) Parkin deficiency delays motor decline and disease manifestation in a mouse model of synucleinopathy. PLoS One 4: e6629.
43. Chinopoulos C, Zhang SF, Thomas B, Ten V, Starkov AA (2011) Isolation and functional assessment of mitochondria from small amounts of mouse brain tissue. Methods Mol Biol 793: 311-324.
44. Friedman WJ, Ibanez CF, Hallbook F, Persson H, Cain LD, et al. (1993) Differential actions of neurotrophins in the locus coeruleus and basal forebrain. Exp Neurol 119: 72-78. (Pubitemid 23074243)
45. Morganti MC, Taylor J, Pesheva P, Schachner M (1990) Oligodendrocyte- derived J1-160/180 extracellular matrix glycoproteins are adhesive or repulsive depending on the partner cell type and time of interaction. Exp Neurol 109: 98-110. (Pubitemid 20226709)
46. Wu M, Neilson A, Swift AL, Moran R, Tamagnine J, et al. (2007) Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells. Am J Physiol Cell Physiol 292: C125-136. (Pubitemid 46115126)
47. Medja F, Allouche S, Frachon P, Jardel C, Malgat M, et al. (2009) Development and implementation of standardized respiratory chain spectrophotometric assays for clinical diagnosis. Mitochondrion 9: 331-339.
48. Schagger H, Pfeiffer K (2001) The ratio of oxidative phosphorylation complexes I-V in bovine heart mitochondria and the composition of respiratory chain supercomplexes. J Biol Chem 276: 37861-37867.
49. Couplan E, Gelly C, Goubern M, Fleury C, Quesson B, et al. (2002) High level of uncoupling protein 1 expression in muscle of transgenic mice selectively affects muscles at rest and decreases their IIb fiber content. J Biol Chem 277: 43079-43088. (Pubitemid 35285690)
50. Viengchareun S, Caron M, Auclair M, Kim MJ, Frachon P, et al. (2007) Mitochondrial toxicity of indinavir, stavudine and zidovudine involves multiple cellular targets in white and brown adipocytes. Antivir Ther 12: 919-929. (Pubitemid 47492561)
51. Auchere F, Santos R, Planamente S, Lesuisse E, Camadro JM (2008) Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia. Hum Mol Genet 17: 2790-2802.
52. Bulteau AL, Dancis A, Gareil M, Montagne JJ, Camadro JM, et al. (2007) Oxidative stress and protease dysfunction in the yeast model of Friedreich ataxia. Free Radic Biol Med 42: 1561-1570. (Pubitemid 46613940)
53. Magistretti PJ, Pellerin L (1996) Cellular mechanisms of brain energy metabolism. Relevance to functional brain imaging and to neurodegenerative disorders. Ann N Y Acad Sci 777: 380-387.
54. Larsen NJ, Ambrosi G, Mullett SJ, Berman SB, Hinkle DA (2011) DJ-1 knockdown impairs astrocyte mitochondrial function. Neuroscience 196: 251-264.
55. Gimenez-Cassina A, Martinez-Francois JR, Fisher JK, Szlyk B, Polak K, et al. (2012) BAD-dependent regulation of fuel metabolism and K(ATP) channel activity confers resistance to epileptic seizures. Neuron 74: 719-730.
56. Chen H, Chan DC (2009) Mitochondrial dynamics-fusion, fission, movement, and mitophagy-in neurodegenerative diseases. Hum Mol Genet 18: R169-176.
57. Flinn L, Mortiboys H, Volkmann K, Koster RW, Ingham PW, et al. (2009) Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 132: 1613-1623.
58. Kirby DM, Thorburn DR, Turnbull DM, Taylor RW (2007) Biochemical assays of respiratory chain complex activity. Methods Cell Biol 80: 93-119.
59. Macmillan-Crow LA, Cruthirds DL (2001) Invited review: manganese superoxide dismutase in disease. Free Radic Res 34: 325-336. (Pubitemid 32331659)
60. Dagda RK, Gusdon AM, Pien I, Strack S, Green S, et al. (2011) Mitochondrially localized PKA reverses mitochondrial pathology and dysfunction in a cellular model of Parkinson's disease. Cell Death Differ 18: 1914-1923.
61. Kubli DA, Zhang X, Lee Y, Hanna RA, Quinsay MN, et al. (2013) Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J Biol Chem 288: 915-926.
62. Kubli DA, Quinsay MN, Gustafsson AB (2013) Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun Integr Biol 6: e24511.
63. Harman D (1972) The biologic clock: the mitochondria? J Am Geriatr Soc 20: 145-147.
64. Moisoi N, Fedele V, Edwards J, Martins LM (2014) Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress. Neuropharmacology 77: 350-357.